References
- WongJKHezarehMGünthardHFRecovery of replication-competent HIV despite prolonged suppression of plasma viremiaScience1997278129112959360926
- DaveyRTJrBhatNYoderCHIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionProc Natl Acad Sci U S A199996151091511410611346
- PalmerSJosefssonLCoffinJMHIV reservoirs and the possibility of a cure for HIV infectionJ Intern Med201127055056021929712
- FinziDHermankovaMPiersonTIdentification of a reservoir for HIV-1 in patients on highly active antiretroviral therapyScience1997278129513009360927
- ChunTWFauciASHIV reservoirs: pathogenesis and obstacles to viral eradication and cureAIDS2012261261126822472858
- ChanCNDietrichIHosieMJWillettBJRecent developments in human immunodeficiency virus-1 latency researchJ Gen Virol20139491793223364195
- ColemanCMWuLHIV interactions with monocytes and dendritic cells: viral latency and reservoirsRetrovirology200965119486514
- GavegnanoCSchinaziRFAntiretrovial therapy in macrophages: implication for HIV eradicationAntivir Chem Chemother200920637819843977
- Le DouceVHerbeinGRohrOSchwartzCMolecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineageRetrovirology201073220380694
- BestBMLetendreSLKoopmansPCHARTER Study GroupLow cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovirJ Acquir Immune Defic Syndr20125937638122217676
- GartnerSMarkovitsPMarkovitzDMKaplanMHGalloRCPopovicMThe role of mononuclear phagocytes in HTLVIII/LAV infectionScience19862332152193014648
- VeraniAGrasGPancinoGMacrophages and HIV-1: dangerous liaisonsMol Immunol20054219521215488608
- VenzkeSKepplerOTRole of macrophages in HIV infection and persistenceExpert Rev Clin Immunol2006261362620477617
- KoppensteinerHBrack-WernerRSchindlerMMacrophages and their relevance in Human Immunodeficiency Virus Type I infectionRetrovirology201298223035819
- KumarAAbbasWHerbeinGHIV-1 latency in monocytes/macrophagesViruses201461837186024759213
- CampbellJHHearpsACMartinGEThe importance of mono-cytes and macrophages in HIV pathogenesis, treatment, and cure. I20142821752187
- EiseleESilicianoRFRedefining the viral reservoirs that prevent HIV-1 eradicationImmunity20123737738822999944
- JorajuriaSDereuddre-BosquetNBecherFATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophagesAntivir Ther2004951952815456083
- AmijiMMVyasTKShahLKRole of nanotechnology in HIV/AIDS treatment: potential to overcome the viral reservoir challengeDiscov Med2006615716217234137
- das NevesJAmijiMMBahiaMFSarmentoBNanotechnology-based systems for the treatment and prevention of HIV/AIDSAdv Drug Deliv Rev20106245847719914314
- van’t KloosterGHoebenEBorghysHPharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulationAntimicrob Agents Chemother2010542042205020160045
- WongHLChattopadhyayNWuXYBendayanRNanotechnology applications for improved delivery of antiretroviral drugs to the brainAdv Drug Deliv Rev20106250351719914319
- RoyUMcMillanJAlnoutiYPharmacodynamic and antiretro-viral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte: reconstituted miceJ Infect Dis20122061577158822811299
- LenjisaJLWolduMASatessaGDNew hope for eradication of HIV from the body: the role of polymeric nanomedicines in HIV/AIDS pharmacotherapyJ Nanobiotechnology201412924655921
- MahajanSDAalinkeelRLawWCAnti-HIV-1 nanotherapeutics: promises and challenges for the futureInt J Nanomedicine201275301531423055735
- CoryTSchackerTWStevensonMFletcherCVOvercoming phar-malogical sanctuariesCurr Opin HIV AIDS2013819019523454865
- LavigneCSlaterKGajanayakaNInfluence of lipoplex surface charge on siRNA: application to the in vitro downregulation of CXCR4 HIV-1 co-receptorExpert Opin Biol Ther20131397398523289797
- KellAJSlaterKBarnesMLLavigneCFunctionalized silica nano-particles stable in serum-containing medium efficiently deliver siRNA targeting HIV-1 co-receptor CXCR4 in mammalian cellsInt J Nano Biomater20124223242
- DestacheCJBelgumTGoedeMShibataABelshanMAAntiretro-viral release from poly(DL-lactide-co-glycolide) nanoparticles in miceJ Antimicrob Chemother2010652183218720729545
- LüJMWangXMarin-MullerCCurrent advances in research and clinical applications of PLGA-based nanotechnologyExpert Rev Mol Diagn2009932534119435455
- SemeteBBooysenLLemmerYIn vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systemsNanomedicine2010666267120230912
- DanhierFAnsorenaESilvaJMCocoRLe BretonAPréatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release201216150552222353619
- DesaiNChallenges in development of nanoparticle-based therapeuticsAAPS J20121428229522407288
- MoghimiSMParhamifarLAhmadvandDParticulate systems for targeting of macrophages: basic and therapeutic conceptsJ Innate Immun2012450952822722900
- KumariAYadavSKYadavSCBiodegradable polymeric nanopar-ticles based drug delivery systemsColloids Surf B Biointerfaces20107511819782542
- ThomasCRawatAHope-WeeksLAshanFAerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccineMol Pharm2011840541521189035
- ChitkaraDKumarNBSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugsPharm Res2013302396240923756758
- DestacheCJBelgumTChristensenKCombination antiretroviral drugs in PLGA nanoparticle for HIV-1. BI20099198
- ShibataAMcMullenEPhamAPolymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatmentAIDS Res Hum Retroviruses20132974675423289671
- EdagwaBJGuoDPuligujjaPJoEllynHCLong-acting antitubercu-lous therapeutic nanoparticles target macrophage endosomesFASEB J2014285071508225122556
- PanyamJZhouWZPrabhaSSahooSKLabhasetwarVRapid endo-lysosomal escape of poly(DL-lactide-coglycolide) nanoparticles: implications for drug and gene deliveryFASEB J2002161217122612153989
- KumarRSahooGCPandeyKDasVDasPStudy the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovaniDrug Deliv201522338338824601828
- TsuchiyaSYamabeMYamaguchiYKobayashiYKonnoTTadaKEstablishment and characterization of a human acute monocytic leukemia cell line (THP-1)Int J Cancer1980261711766970727
- TsuchiyaSKobayashiYGotoYInduction of maturation in cultured human monocytic leukemia cells by a phorbol diesterCancer Res198242153015366949641
- PelletierMBouchardAGirardDIn vivo and in vitro roles of IL-21 in inflammationJ Immunol20041737521753015585879
- BinetFCavalliHMoisanEGirardDArsenic trioxide (AT) is a novel human neutrophil pro-apoptotic agent: effects of catalase on AT-induced apoptosis, degradation of cytoskeletal proteins and de novo protein synthesisBr J Haematol200613234935816409300
- GoncalvesDMChiassonSGirardDActivation of human neutrophils by titanium dioxide (TiO2) nanoparticlesToxicol In Vitro2010241002100820005940
- LavastreVCavalliHRattheCGirardDAnti-inflammatory effect of Viscum album agglutinin-I (VAA-I): induction of apoptosis in activated neutrophils and inhibition of lipopolysaccharide-induced neutrophilic inflammation in vivoClin Exp Immunol200413727227815270843
- PelletierMGirardDBiological functions of interleukin-21 and its role in inflammationScientific World Journal200771715173517982568
- RattheCEnnaciriJGarces GoncalvesDMChiassonSGirardDInterleukin (IL)-4 induces leukocyte infiltration in vivo by an indirect mechanismMediators Inflamm2009200919397019753321
- LavastreVPelletierMSallerRHostanskaKGirardDMechanisms involved in spontaneous and Viscum album agglutinin-I (VAA-I)-induced human neutrophil apoptosis: VAA-I accelerates the loss of the antiapoptotic Mcl-1 expression and the degradation of the cytoskeletal paxillin and vimentin proteins via caspasesJ Immunol20021681419142711801684
- KobayashiSDVoyichJMWhitneyARDeLeoFRSpontaneous neutro-phil apoptosis and regulation of cell survival by granulocyte macrophage-colony stimulating factorJ Leukoc Biol2005781408141816204629
- GonçalvesDMGirardDTitanium dioxide (TiO2) nanoparticles induce neutrophil influx and local production of several pro-inflammatory mediators in vivoInt Immunopharmacol2011111109111521426949
- GonçalvesDMGirardDEvidence that polyhydroxylated C60 Fullerene (Fullerenol) nanoparticles amplify the effect of lipopolysaccharides to induce a rapid leukocyte infiltration in vivoChem Res Toxicol2013261884189224191652
- VandoorenJBerghmansNDillenCIntradermal air pouch leukocytosis as an in vivo test for nanoparticlesInt J Nanomedicine201384745475624379662
- ChellatFGrandjean-LaquerriereALe NaourRMetalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticlesBiomaterials20052696197015369684
- ChenHWSuSFChienCTTitanium dioxide nanoparticles induce emphysema-like lung injury in miceFASEB J2006202393239517023518
- GrabowskiNHillaireauHVergnaudJSurface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophagesInt J Pharm20154821–2758325448553
- HussainSVanoirbeekJALuytsKLung exposure to nanoparticles modulates an asthmatic response in a mouse modelEur Respir J20113729930920530043
- SrinivasARaoPJSelvamGMurthyPBReddyPNAcute inhalation toxicity of cerium oxide nanoparticles in ratsToxicol Lett20112323
- BrandenbergerCRowleyNLJackson-HumblesDNEngineered silica nanoparticles act as adjuvants to enhance allergic airway disease in micePart Fibre Toxicol2013102623815813
- NathanCNeutrophils and immunity: challenges and opportunitiesNat Rev Immunol2006617318216498448
- WrightHLMootsRJBucknallRCEdwardsSWNeutrophil function in inflammation and inflammatory diseasesRheumatology (Oxford)2010491618163120338884
- GoncalvesDMGirardDZinc oxide nanoparticles delay human neutrophil apoptosis by a de novo protein synthesis-dependent and reactive oxygen species-independent mechanismToxicol In Vitro20142892693124759804